News & Media

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018

August 1, 2018

GAITHERSBURG, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter 2018 financial and operating results following the close of U.S. financial markets on Wednesday, August 8, 2018.

Conference call details are as follows:

Date:August 8, 2018
Time:4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:(877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:5886748
Webcast:www.novavax.com, “Investors”/ “Events”
 
Conference call and webcast replay:
  
Dates:Starting at 7:30 p.m. ET, August 8, 2018 until 7:30 p.m. ET August 15, 2018
Dial-in number:(855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:  5886748
Webcast:  www.novavax.com, “Investors”/ “Events”, until November 8, 2018
 

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases. It’s RSV and influenza nanoparticle vaccine candidates are Novavax’ most advanced clinical programs and are at the forefront of Novavax’ efforts to improve global health. For more information, please visit www.novavax.com.

Contact:        

Investors
Erika Trahan
Senior Manager, Investor & Public Relations
[email protected]
240-268-2000

Westwicke Partners
John Woolford
[email protected] 
443-213-0506

Media
Sam Brown
Mike Beyer 
[email protected] 
312-961-2502

The scientific images on this website are generated or enhanced using artificial intelligence. These visuals are for illustrative purposes only. Illustrations of Matrix-M and Protein Nanoparticles are visual representations only.

©2026 Novavax. All rights reserved.